About Me

My research program employs RNA aptamers for selective targeting to interrupt the development of disease. We explore novel approaches for treating acute respiratory distress syndrome (ARDS), multiple organ dysfunction syndrome (MODS), complications of sepsis, and arterial neointimal hyperplasia.